Deniz Yılmaz Karapınar
1:45 pm
-
2:00 pm
Exhibition Hall
The place of MRD in the management of ALL
Minimal Residual Disease (MRD) assessment plays a critical role in the management of Acute Lymphoblastic Leukemia (ALL). MRD refers to the small number of leukemia cells that remain in the body after treatment and become undetectable using standard methods. The presence of MRD is associated with a higher risk of relapse, while achieving and maintaining MRD negativity is correlated with better treatment outcomes.
2:30 pm
-
2:45 pm
Exhibition Hall
Panel discussion /All speakers
Panel discussion /All speakers for Panel discussion /All speakers